Solutions to Improve COPD Patients’ Clinical Outcomes and Quality of Care: Recommendations From the CARABELA Initiative
These recommendations are intended to close the gap between evidence-based guidelines and real clinical practice, so that every patient receives high-quality individualized care. Through collaboration between healthcare professionals, scientific societies, and policymakers, CARABELA-COPD seeks to reduce disparities in care, enhance system effectiveness, and ultimately improve quality of life for patients with COPD.
Authors
- Jesús Díez‐Manglano (ORCID: https://orcid.org/0000-0002-3132-2171)
- Javier de Miguel-Diez
- Inmaculada Mediavilla
- Luciano Escudero
Institutions
- Universidad Complutense de Madrid (ES)
- Universidad de Zaragoza (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Royo Villanova (ES)
- Madrid Health Service (ES)
- AstraZeneca (Spain) (ES)
Publication Details
- Journal
- Open Respiratory Archives
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.opresp.2025.100484
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- Teva Pharmaceutical Industries
- CSL Behring
- Nestlé Health Science
- AstraZeneca España
- Novo Nordisk
- Grifols